| Announce Date | 08/07/2025 | 
| EPS Normalized Actual | $-0.56 (Miss by $-0.49) | 
| EPS GAAP Actual | $-0.56 (Miss by $-0.49) | 
| Revenue Actual | $0.1813B | 
| Revenue Surprise | Beat by $181.3M | 
| Announce Date | 10/01/2025 (Pre-Market) | 
| EPS Normalized Estimate | $0.13 | 
| EPS GAAP Estimate | $0.13 | 
| Revenue Estimate | $0.1898705B | 
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts | 
|---|---|---|---|---|---|
| Dec 2026 | 0.87 | 16.44 | 0.86132 | 0.87962 | 0 | 
| Dec 2025 | 0.86 | 16.63 | 0.36 | 1.36 | 2 | 
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss | 
|---|---|---|---|---|---|
| FQ2 2025 (Jun 2025) | -0.46 | -0.46 | 0.1813B | -1.09% | 181.3M | 
| FQ1 2025 (Mar 2025) | -0.69 | -0.69 | 0.179294B | -4.18% | 179.29M | 
| FQ4 2024 (Dec 2024) | -0.31 | -0.31 | 0.180548B | -10.2% | 180.55M | 
| FQ3 2024 (Sep 2024) | -3.21 | -3.21 | 0.178452B | -7.05% | 178.45M | 
| FQ2 2024 (Jun 2024) | 0.59 | 0.59 | 0.183281B | -1.72% | 183.28M | 
| FQ1 2024 (Mar 2024) | -0.41 | -0.41 | 0.186794B | 0.55% | 186.79M | 
| FQ4 2023 (Dec 2023) | -0.47 | -0.47 | 0.198966B | 3.49% | 198.97M | 
| FQ3 2023 (Sep 2023) | -0.27 | -0.27 | 0.191036B | 4.62% | 191.04M | 
FQ4 Announce Date
10/01/2025 (Pre-Market)
Consensus EPS Estimates
0.13
Consensus Revenue Estimates
0.1898705B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts | 
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | -0.11 | -- | -0.11024 | -0.10976 | 1 | 
| FQ3 2027 (Sep 2027) | 0.26 | -- | 0.26 | 0.26 | 1 | 
| FQ2 2027 (Jun 2027) | -0.4 | -- | -0.4 | -0.4 | 1 | 
| FQ1 2027 (Mar 2027) | -0.07 | -- | -0.07014986 | -0.0698489 | 1 | 
| FQ4 2026 (Oct 2026) | 0.2 | -- | 0.19753 | 0.20228 | 0 | 
| FQ3 2026 (Jul 2026) | 0.14 | -- | 0.13827 | 0.1416 | 0 | 
| FQ2 2026 (Jun 2026) | 0.14 | 428.57 | 0.1394 | 0.14086 | 0 | 
| FQ1 2026 (Mar 2026) | -0.02 | -3350 | -0.02011508 | -0.01992 | 0 | 
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts | 
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 0.19B | -- | 0.19B | 0.19B | 1 | 
| FQ3 2027 (Sep 2027) | 0.19B | -- | 0.19B | 0.19B | 1 | 
| FQ2 2027 (Jun 2027) | 0.19B | -- | 0.19B | 0.19B | 1 | 
| FQ1 2027 (Mar 2027) | 0.18B | -- | 0.18B | 0.18B | 1 | 
| FQ4 2026 (Oct 2026) | 0.19B | -- | 0.19B | 0.19B | 1 | 
| FQ3 2026 (Jul 2026) | 0.19B | -- | 0.19B | 0.19B | 1 | 
| FQ2 2026 (Jun 2026) | 0.19B | 3.75 | 0.19B | 0.19B | 1 | 
| FQ1 2026 (Mar 2026) | 0.19B | 3.49 | 0.19B | 0.19B | 1 | 
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts | 
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 | 
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 | 
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 | 
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 | 
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts | 
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 | 
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 | 
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 | 
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 | 
EPS # of Beats
1
EPS # of Misses
7
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % | 
|---|---|---|---|---|
| FQ2 2025 (Jun 2025) | -0.46 | -0.46 | 100% | |
| FQ1 2025 (Mar 2025) | -0.69 | -0.69 | 100% | |
| FQ4 2024 (Dec 2024) | -0.31 | -0.31 | 100% | |
| FQ3 2024 (Sep 2024) | -3.21 | -3.21 | 100% | |
| FQ2 2024 (Jun 2024) | 0.59 | 0.59 | 100% | |
| FQ1 2024 (Mar 2024) | -0.41 | -0.41 | 100% | |
| FQ4 2023 (Dec 2023) | -0.47 | -0.47 | 100% | |
| FQ3 2023 (Sep 2023) | -0.27 | -0.27 | 100% | 
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % | 
|---|---|---|---|---|
| FQ2 2025 (Jun 2025) | $0B | $0.18B | $181.3M | 100% | 
| FQ1 2025 (Mar 2025) | $0B | $0.18B | $179.29M | 100% | 
| FQ4 2024 (Dec 2024) | $0B | $0.18B | $180.55M | 100% | 
| FQ3 2024 (Sep 2024) | $0B | $0.18B | $178.45M | 100% | 
| FQ2 2024 (Jun 2024) | $0B | $0.18B | $183.28M | 100% | 
| FQ1 2024 (Mar 2024) | $0B | $0.19B | $186.79M | 100% | 
| FQ4 2023 (Dec 2023) | $0B | $0.2B | $198.97M | 100% | 
| FQ3 2023 (Sep 2023) | $0B | $0.19B | $191.04M | 100% |